Activation of MYC pathway is a unifying pathological event in the progression from monoclonal gammopathy of undetermined significance (MGUS) to myeloma (MM)

被引:0
|
作者
Chng, Wee J. [1 ]
Chesi, Marta [1 ]
Price-Troska, Tammy [2 ]
Ahmann, Greg [1 ]
Henderson, Kim [2 ]
Greipp, Philip [2 ]
Kyle, Robert [2 ]
Rajkumar, S. Vincent [2 ]
Gertz, Morie [2 ]
Fonseca, Rafael [1 ]
Bergsagel, P. Leif [1 ]
机构
[1] Mayo Clin, Scottsdale, AZ USA
[2] Mayo Clin, Dept Hematol, Rochester, MN USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
241
引用
收藏
页码:78A / 78A
页数:1
相关论文
共 50 条
  • [41] Role of MicroRNAs From Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma
    Calvo, Katherine R.
    Landgren, Ola
    Roccaro, Aldo M.
    Ghobrial, Irene M.
    SEMINARS IN HEMATOLOGY, 2011, 48 (01) : 39 - 45
  • [42] Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression
    Kyle, Robert A.
    Rajkumar, S. Vincent
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 139 (05) : 730 - 743
  • [43] Global quantitative lipidomic profiling of bone marrow (BM) plasma between patients with multiple myeloma (MM) and monoclonal gammopathy of undetermined significance (MGUS)
    Atilgan, Ezgi
    Anderson, Emilie
    Nandakumar, Bharat
    Kumar, Shaji
    Gonsalves, Wilson
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S103 - S103
  • [44] Aberrant gene methylation implicated in the progression of monoclonal gammopathy of undetermined significance to multiple myeloma
    Chim, Chor-Sang
    Liang, Raymond
    Leung, Man-Hin
    Kwong, Yok-Lam
    JOURNAL OF CLINICAL PATHOLOGY, 2007, 60 (01) : 104 - 106
  • [45] Monoclonal gammopathy of undetermined significance and solitary plasmacytoma - Implications for progression to overt multiple myeloma
    Kyle, RA
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1997, 11 (01) : 71 - &
  • [46] Predictive Immune Markers for Disease Progression in Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance
    Isgor, Irem Sahver
    Toptas, Tayfur
    Turkoz, Huseyin Kemal
    TURKISH JOURNAL OF HEMATOLOGY, 2022, 39 (04) : 245 - 253
  • [47] Association of Immune Marker Changes With Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma
    Landgren, Ola
    Hofmann, Jonathan N.
    McShane, Charlene M.
    Santo, Loredana
    Hultcrantz, Malin
    Korde, Neha
    Mailankody, Sham
    Kazandjian, Dickran
    Murata, Kazunori
    Thoren, Katie
    Ramanathan, Lakshmi
    Dogan, Ahmet
    Rustad, Even
    Lu, Sydney X.
    Akhlaghi, Theresia
    Kristinsson, Sigurdur Y.
    Bjorkholm, Magnus
    Devlin, Sean
    Purdue, Mark P.
    Pfeiffer, Ruth M.
    Turesson, Ingemar
    JAMA ONCOLOGY, 2019, 5 (09) : 1293 - 1301
  • [48] Chemokine RANTES (Regulated upon activation, normal T cell expressed and secreted) in multiple myeloma and MGUS (Monoclonal Gammopathy of Undetermined Significance).
    Hayashi, Kunio
    Nomura, Shosaku
    Mugitani, Atsuko
    Hasegawa, Minoru
    Uoshima, Nobuhiko
    Takubo, Takayuki
    Kami, Masahiro
    Komatsu, Tsunehiko
    Hamaki, Tamae
    Shimokawa, Toshio
    BLOOD, 2007, 110 (11) : 262B - 262B
  • [49] A 12 Gene Signature Accurately Predicts Multiple Myeloma Progression from Monoclonal Gammopathy of Undetermined Significance
    Sun, Fumou
    Ying, Jun
    Cheng, Yan
    Mery, David
    Wanchai, Visanu
    Siegel, Eric R.
    Xu, Hongwei
    Gai, Dongzheng
    Xu, Jiahao
    Ashby, Timothy Cody
    Bailey, Clyde
    Al Hadidi, Samer
    Schinke, Carolina
    Thanendrarajan, Sharmilan
    Zangari, Maurizio
    van Rhee, Frits
    Janz, Siegfried
    Tricot, Guido
    Shaughnessy, John D., Jr.
    Zhan, Fenghuang
    BLOOD, 2022, 140
  • [50] Increased prevalence of light chain monoclonal gammopathy of undetermined significance (MGUS) in first-degree relatives of individuals with multiple myeloma or MGUS
    Greenberg, Alexandra J.
    Rajkumar, S. Vincent
    Larson, Dirk R.
    Dispenzieri, Angela
    Therneau, Terry M.
    Colby, Colin L.
    Phelps, Tara K.
    Kumar, Shaji K.
    Katzmann, Jerry A.
    Kyle, Robert A.
    Slager, Susan L.
    Vachon, Celine M.
    CANCER RESEARCH, 2012, 72